Compounds > ornithine

ornithine and Carcinoma, Epidermoid

ornithine has been researched along with Carcinoma, Epidermoid in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's5 (50.00)18.2507
2000's2 (20.00)29.6817
2010's2 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Buas, MF; Chen, C; Djukovic, D; Gu, H; Lohavanichbutr, P; Nagana Gowda, GA; Raftery, D; Wang, P; Zhang, Y1
Ding, D; Liu, XM; Pan, C; Xia, YM; Zhan, N; Zou, XY1
Hoekman, K; Musters, RJ; Niessen, HW; Schalkwijk, CG; van Heijst, JW; van Hinsbergh, VW1
Chen, G; Rosowsky, A; Wright, JE1
Holden, SA; Northey, D; Robinson, MF; Rosowsky, A; Teicher, BA1
Bader, H; Rosowsky, A; Teicher, BA; Vaidya, CM; Wright, JE1
Alperin, WL; Pardo, M; Rosowsky, A; Tretyakov, A; Trites, D; Wright, JE1
Cakir, E; Gülen, S; Süer Gökmen, S; Yörük, Y; Yorulmaz, F1
Aygit, AC; Ayhan, MS; Gökmen, SS; Gülen, S; Yorulmaz, F1
Baylin, SB; Luk, GD1

Other Studies

10 other study(ies) available for ornithine and Carcinoma, Epidermoid

ArticleYear
Salivary metabolite profiling distinguishes patients with oral cavity squamous cell carcinoma from normal controls.
    PloS one, 2018, Volume: 13, Issue:9

    Topics: Adult; Aged; Biomarkers, Tumor; Carcinoma, Squamous Cell; Chromatography, Liquid; Citrulline; Early Detection of Cancer; Female; Glycine; Humans; Linear Models; Magnetic Resonance Spectroscopy; Male; Metabolomics; Middle Aged; Mouth Neoplasms; Neoplasm Staging; Ornithine; Oropharyngeal Neoplasms; Proline; Saliva; Tandem Mass Spectrometry

2018
Glyoxalase I is differentially expressed in cutaneous neoplasms and contributes to the progression of squamous cell carcinoma.
    The Journal of investigative dermatology, 2015, Volume: 135, Issue:2

    Topics: Animals; Apoptosis; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Disease Progression; Humans; Lactoylglutathione Lyase; Male; Mice; Neoplasm Invasiveness; NF-kappa B; Ornithine; Pyrimidines; Pyruvaldehyde; Skin Neoplasms; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays

2015
Argpyrimidine-modified Heat shock protein 27 in human non-small cell lung cancer: a possible mechanism for evasion of apoptosis.
    Cancer letters, 2006, Sep-28, Volume: 241, Issue:2

    Topics: Adenocarcinoma; Apoptosis; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Caspase 3; Caspases; Enzyme-Linked Immunosorbent Assay; Glucose; Glycation End Products, Advanced; Glycolysis; Heat-Shock Proteins; Humans; Lung Neoplasms; Ornithine; Pyrimidines; Tumor Cells, Cultured

2006
Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    Molecular pharmacology, 1995, Volume: 48, Issue:4

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Kinetics; Methotrexate; Ornithine; Pterins; Pteroylpolyglutamic Acids; Quinazolines; Tetrahydrofolate Dehydrogenase; Tritium; Tumor Cells, Cultured

1995
Antifolates can potentiate topoisomerase II inhibitors in vitro and in vivo.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:2

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Cell Line; Cell Survival; DNA Damage; DNA, Neoplasm; Drug Synergism; Etoposide; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Male; Methotrexate; Mice; Mice, Inbred C3H; Novobiocin; Ornithine; Pterins; Topoisomerase II Inhibitors; Trimetrexate; Tumor Cells, Cultured

1995
Analogues of N alpha-(4-amino-4-deoxypteroyl)-N delta-hemiphthaloyl-L-ornithine (PT523) modified in the side chain: synthesis and biological evaluation.
    Journal of medicinal chemistry, 1997, Jan-31, Volume: 40, Issue:3

    Topics: Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cell Division; Drug Screening Assays, Antitumor; Folic Acid Antagonists; Glutamates; Humans; Magnetic Resonance Spectroscopy; Methotrexate; Mice; Molecular Structure; Ornithine; Pterins; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Tumor Cells, Cultured

1997
Pharmacokinetics, antifolate activity and tissue distribution of PT523 in SCC VII tumor-bearing mice.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:4

    Topics: Animals; Antineoplastic Agents; Area Under Curve; Carbon Radioisotopes; Carcinoma, Squamous Cell; Folic Acid Antagonists; Injections, Intravenous; Isotope Labeling; Male; Methotrexate; Mice; Mice, Inbred C3H; Neoplasms, Experimental; Ornithine; Pterins; Tetrahydrofolates; Tissue Distribution

1998
Arginase and ornithine, as markers in human non-small cell lung carcinoma.
    Cancer biochemistry biophysics, 1999, Volume: 17, Issue:1-2

    Topics: Adenocarcinoma; Aged; Arginase; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Humans; Lung; Lung Neoplasms; Middle Aged; Neoplasm Proteins; Ornithine

1999
Significance of arginase and ornithine in malignant tumors of the human skin.
    The Journal of laboratory and clinical medicine, 2001, Volume: 137, Issue:5

    Topics: Arginase; Biomarkers; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Humans; Male; Middle Aged; Ornithine; Skin; Skin Neoplasms

2001
Anchorage dependency effects on difluoromethylornithine cytotoxicity in human lung carcinoma cells.
    Cancer research, 1986, Volume: 46, Issue:4 Pt 1

    Topics: Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cell Aggregation; Cell Communication; Cell Survival; Cells, Cultured; Cytoskeleton; Eflornithine; Humans; Lung Neoplasms; Ornithine; Polyamines

1986